Visit 1 Visit 2 Visit 3   Patient number (n=1385) % Patient number (n=1379) % Patient number (n=1358) % Rosuvastatin 1308 94.4 1326 96.2 1311 96.5 Ezetimibe 64 4.7 72 5.2 99 7.3 Atorvastatin 30 2.2 19 1.4 18 1.3 Simvastatin 21 1.5 15 1.1 16 1.2 Fenofibrate 28 2.0 25 1.8 30 2.2

Table 3: Proportion of recommended lipid lowering drugs at the visits (drugs with an occurrence of at least 1%; more than one drug may belong to one patient).